Age-related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy

Synapse

Volumn 68, Issue 3, 2014, Pages 98-106

  Fernagut, P O ^a,b   Meissner, W G ^a,b,c   Biran, M ^a   Fantin, M ^a,d   Bassil, F ^a,b   Franconi, J M ^a   Tison, F ^a,b,c  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSTITUT DES MALADIES NEURODÉGÉNÉRATIVES   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY OF FERRARA   (Italy)

Author keywords

Alpha synuclein; Magnetic resonance imaging; Motor behavior; Multiple system atrophy

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE; PROTEOLIPID;

AGE RELATED MOTOR DYSFUNCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN SIZE; BRAIN VENTRICLE; CELL LOSS; CONTROLLED STUDY; DISEASE ASSOCIATION; METABOLITE; MORPHOMETRICS; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHY DRAGER SYNDROME; WILD TYPE;

ALPHA-SYNUCLEIN; MAGNETIC RESONANCE IMAGING; MOTOR BEHAVIOR; MULTIPLE SYSTEM ATROPHY;

AGE FACTORS; ALPHA-SYNUCLEIN; ANIMALS; ATROPHY; BRAIN; CELL DEATH; CEREBRAL VENTRICLES; CORPUS STRIATUM; DOPAMINE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; MOVEMENT DISORDERS; MULTIPLE SYSTEM ATROPHY; NEUROGLIA; ORGAN SIZE;

EID: 84892673866     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21719     Document Type: Article

References (32)

1. Abramoff MD, Magalhaes PJ, Ram SJ. 2004. Image processing with ImageJ. Biophotonics Int 11:36-42.
2. Ahmed Z, Asi YT, Lees AJ, Revesz T, Holton JL. 2013. Identification and quantification of oligodendrocyte precursor cells in multiple system atrophy, progressive supranuclear palsy and Parkinson's disease. Brain Pathol 23:263-273.
3. Brenneis C, Seppi K, Schocke MF, Muller J, Luginger E, Bosch S, Loscher WN, Buchel C, Poewe W, Wenning GK. 2003. Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy. Mov Disord 18:1132-1138.
4. Brooks SP, Dunnett SB. 2009. Tests to assess motor phenotype in mice: A user's guide. Nat Rev Neurosci 10:519-529.
5. Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, Bates GP, Dunnett SB, Morton AJ. 1999. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci 19:3248-3257.
6. Diguet E, Fernagut PO, Scherfler C, Wenning G, Tison F. 2005. Effects of riluzole on combined MPTP+3-nitropropionic acid-induced mild to moderate striatonigral degeneration in mice. J Neural Transm 112:613-631.
7. Elsworth JD, Roth RH. 1997. Dopamine synthesis, uptake, metabolism, and receptors: Relevance to gene therapy of Parkinson's disease. Exp Neurol 144:4-9.
8. Fearnley JM, Lees AJ. 1990. Striatonigral degeneration. A clinicopathological study. Brain 113 (Part 6):1823-1842.
9. Fellner L, Jellinger KA, Wenning GK, Stefanova N. 2011. Glial dysfunction in the pathogenesis of alpha-synucleinopathies: Emerging concepts. Acta Neuropathol 121:675-693.
10. Fernagut PO, Chesselet MF. 2004. Alpha-synuclein and transgenic mouse models. Neurobiol Dis 17:123-130.
11. Fernagut PO, Diguet E, Bioulac B, Tison F. 2004. MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: Reference to striatonigral degeneration. Exp Neurol 185:47-62.
12. Fernagut PO, Hutson CB, Fleming SM, Tetreaut NA, Salcedo J, Masliah E, Chesselet MF. 2007. Behavioral and histopathological consequences of paraquat intoxication in mice: Effects of alpha-synuclein over-expression. Synapse 61:991-1001.
13. Fernagut PO, Tison F. 2012. Animal models of multiple system atrophy. Neuroscience 211:77-82.
14. Fleming SM. 2009. Behavioral outcome measures for the assessment of sensorimotor function in animal models of movement disorders. Int Rev Neurobiol 89:57-65.
15. Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA, Bhatnagar A, Meloni EG, Wu N, Ackerson LC, Klapstein GJ, Gajendiran M, Roth BL, Chesselet MF, Maidment NT, Levine MS, Shen J. 2003. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem 278:43628-43635.
16. Ishizawa K, Komori T, Sasaki S, Arai N, Mizutani T, Hirose T. 2004. Microglial activation parallels system degeneration in multiple system atrophy. J Neuropathol Exp Neurol 63:43-52.
17. Kahle PJ. 2008. alpha-Synucleinopathy models and human neuropathology: Similarities and differences. Acta Neuropathol 115:87-95.
18. Kahle PJ, Neumann M, Ozmen L, Muller V, Jacobsen H, Spooren W, Fuss B, Mallon B, Macklin WB, Fujiwara H, Hasegawa M, Iwatsubo T, Kretzschmar HA, Haass C. 2002. Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes. EMBO Rep 3:583-588.
19. Kikuchi A, Takeda A, Okamura N, Tashiro M, Hasegawa T, Furumoto S, Kobayashi M, Sugeno N, Baba T, Miki Y, Mori F, Wakabayashi K, Funaki Y, Iwata R, Takahashi S, Fukuda H, Arai H, Kudo Y, Yanai K, Itoyama Y. 2010. In vivo visualization of alpha-synuclein deposition by carbon-11-labelled 2-[2-(2-dimethylaminothiazol-5-yl)ethenyl]-6-[2-(fluoro)ethoxy]benzoxazole positron emission tomography in multiple system atrophy. Brain 133 (Part 6):1772-1778.
20. Konagaya M, Konagaya Y, Sakai M, Matsuoka Y, Hashizume Y. 2002. Progressive cerebral atrophy in multiple system atrophy. J Neurol Sci 195:123-127.
21. McCormack AL, Thiruchelvam M, Manning-Bog AB, Thiffault C, Langston JW, Cory-Slechta DA, Di Monte DA. 2002. Environmental risk factors and Parkinson's disease: Selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol Dis 10:119-127.
22. Messina D, Cerasa A, Condino F, Arabia G, Novellino F, Nicoletti G, Salsone M, Morelli M, Lanza PL, Quattrone A. 2011. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Parkinsonism Relat Disord 17:172-176.
23. Plaas M, Karis A, Innos J, Rebane E, Baekelandt V, Vaarmann A, Luuk H, Vasar E, Koks S. 2008. Alpha-synuclein A30P point-mutation generates age-dependent nigrostriatal deficiency in mice. J Physiol Pharmacol 59:205-216.
24. Shults CW, Rockenstein E, Crews L, Adame A, Mante M, Larrea G, Hashimoto M, Song D, Iwatsubo T, Tsuboi K, Masliah E. 2005. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: Implications for multiple system atrophy. J Neurosci 25:10689-10699.
25. Song YJ, Lundvig DM, Huang Y, Gai WP, Blumbergs PC, Hojrup P, Otzen D, Halliday GM, Jensen PH. 2007. p25alpha Relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy. Am J Pathol 171:1291-1303.
26. Stefanova N, Reindl M, Neumann M, Haass C, Poewe W, Kahle PJ, Wenning GK. 2005. Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy. Am J Pathol 166:869-876.
27. Stefanova N, Reindl M, Neumann M, Kahle PJ, Poewe W, Wenning GK. 2007. Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: Implications for multiple system atrophy. Mov Disord 22:2196-2203.
28. Taylor TN, Greene JG, Miller GW. 2010. Behavioral phenotyping of mouse models of Parkinson's disease. Behav Brain Res 211:1-10.
29. Tillerson JL, Caudle WM, Reveron ME, Miller GW. 2002. Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. Exp Neurol 178:80-90.
30. Ubhi K, Rockenstein E, Mante M, Inglis C, Adame A, Patrick C, Whitney K, Masliah E. 2010. Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors. J Neurosci 30:6236-6246.
31. West MJ, Slomianka L, Gundersen HJ. 1991. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 231:482-497.
32. Yazawa I, Giasson BI, Sasaki R, Zhang B, Joyce S, Uryu K, Trojanowski JQ, Lee VM. 2005. Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron 45:847-859.